These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23673555)

  • 1. Cellular uptake mechanism and therapeutic utility of a novel peptide in targeted-delivery of proteins into neuronal cells.
    Fu A; Zhao Z; Gao F; Zhang M
    Pharm Res; 2013 Aug; 30(8):2108-17. PubMed ID: 23673555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier.
    Fu A; Zhou QH; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Brain Res; 2010 Sep; 1352():208-13. PubMed ID: 20599807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys.
    Garbayo E; Ansorena E; Lana H; Carmona-Abellan MD; Marcilla I; Lanciego JL; Luquin MR; Blanco-Prieto MJ
    Biomaterials; 2016 Dec; 110():11-23. PubMed ID: 27697668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel peptide delivers plasmids across blood-brain barrier into neuronal cells as a single-component transfer vector.
    Fu A; Zhang M; Gao F; Xu X; Chen Z
    PLoS One; 2013; 8(3):e59642. PubMed ID: 23555734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide.
    Fu A; Wang Y; Zhan L; Zhou R
    Pharm Res; 2012 Jun; 29(6):1562-9. PubMed ID: 22231987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
    Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
    eNeuro; 2017; 4(1):. PubMed ID: 28303260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
    Connor B
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy.
    Zhang Y; Pardridge WM
    Pharm Res; 2009 May; 26(5):1059-63. PubMed ID: 19104914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats.
    Bender TS; Migliore MM; Campbell RB; John Gatley S; Waszczak BL
    Neuroscience; 2015 Sep; 303():569-76. PubMed ID: 26166725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.
    Hernando S; Herran E; Figueiro-Silva J; Pedraz JL; Igartua M; Carro E; Hernandez RM
    Mol Neurobiol; 2018 Jan; 55(1):145-155. PubMed ID: 28866799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.
    Yue P; Gao L; Wang X; Ding X; Teng J
    Neurochem Res; 2017 May; 42(5):1366-1374. PubMed ID: 28247332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Drug Metab Dispos; 2010 Apr; 38(4):566-72. PubMed ID: 20075191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter.
    Xia CF; Boado RJ; Zhang Y; Chu C; Pardridge WM
    J Gene Med; 2008 Mar; 10(3):306-15. PubMed ID: 18085726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dampened Amphetamine-Stimulated Behavior and Altered Dopamine Transporter Function in the Absence of Brain GDNF.
    Kopra JJ; Panhelainen A; Af Bjerkén S; Porokuokka LL; Varendi K; Olfat S; Montonen H; Piepponen TP; Saarma M; Andressoo JO
    J Neurosci; 2017 Feb; 37(6):1581-1590. PubMed ID: 28096470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease.
    Wang X; Cui G; Yang X; Zhang Z; Shi H; Zu J; Hua F; Shen X
    Brain Res Bull; 2014 Apr; 103():60-5. PubMed ID: 24583079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
    Glavaski-Joksimovic A; Virag T; Mangatu TA; McGrogan M; Wang XS; Bohn MC
    J Neurosci Res; 2010 Sep; 88(12):2669-81. PubMed ID: 20544825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.